Karol Sikora is Medical Director of CancerPartnersUK which is creating the largest independent cancer network in the UK. He was Professor and Chair of the Department of Cancer Medicine at Imperial College and is still honorary Consultant Oncologist at Hammersmith Hospital, London. He chairs the scientific advisory board of SourceBioscience PLC, Britain's leading cancer diagnostic company. He is Dean of Britain's first independent Medical School at the University of Buckingham and is a Fellow of Corpus Christi College, Cambridge.
He studied medical science and biochemistry at Cambridge, where he obtained a double first. After clinical training he became a house physician at The Middlesex Hospital and registrar in oncology at St Bartholomew's Hospital. He then became a research student at the MRC Laboratory for Molecular Biology in Cambridge working with Nobel Prize winner, Dr. Sydney Brenner. He obtained his PhD and became a clinical fellow at Stanford University, California before returning to direct the Ludwig Institute in Cambridge. He has been Clinical Director for Cancer Services at Hammersmith for 12 years and established a major cancer research laboratory there funded by the Imperial Cancer Research Fund. He chaired Help Hammer Cancer, an appeal that raised £8m towards the construction of the new Cancer Centre at Hammermith. He became Deputy Director (Clinical Research) of the ICRF. From 1997 to 1999 he was Chief of the WHO Cancer Programme and from 1999 to 2002 and Vice President, Global Clinical Research (Oncology) at Pharmacia Corporation.
He has published over 300 papers and written or edited 20 books including Treatment of
Cancer - the standard British postgraduate textbook now going to its fifth
edition and most recently The Economics of Cancer Care. He is on the editorial
board of several journals and is the founding editor of Gene Therapy and Cancer
Strategy. He was a member of the UK Health Department's Expert Advisory Group on
Cancer (the Calman-Hine Committee), the Committee on Safety of Medicines and
remains an adviser to the WHO. He currently directs a cancer drug donation
programme in Africa.
Fax: 0207 518 0781
21 Barrett St, London W1U 1BD
PA: Gill Miller
